Rejuvenate Biomed NV
Latest round
- Series B
Last raised
- Apr 2022
Total raised
- $14M
Investors
- 2
About Rejuvenate Biomed NV
Founded in 2017 and headquartered in Belgium, Rejuvenate Biomed NV specializes in therapeutic solutions for age-related health issues. The company was founded by Ann Belien, who has a notable background in healthcare innovation.Rejuvenate Biomed is primarily focused on developing AI-enabled combination drugs aimed at promoting healthy aging. Their core product, RJx-01, is currently being evaluated in a Phase 2, double-blind, placebo-controlled clinical trial to determine its efficacy in maintaining muscle integrity in older patients experiencing muscle weakness and sarcopenia associated with chronic obstructive pulmonary disease (COPD). This clinical stage product addresses significant health concerns for elderly populations, specifically targeting age-related muscle degeneration and enhancing the quality of life for those affected.Rejuvenate Biomed's revenue structure is built around clinical partnerships and drug development collaborations. The company's offerings, including the flagship RJx-01, are positioned to engage in B2B transactions, where partnerships with research institutions and healthcare organizations facilitate the advancement of their clinical trials. Revenue generation stems from milestone payments associated with the development of their products, as well as potential licensing agreements once products reach market readiness. Future initiatives include further development of RJx-01 and potential new products aimed at addressing additional age-related conditions. The company aims to expand its presence in North America and Europe, targeting specific markets with a growing need for innovative solutions in healthy aging. This strategy is aligned with their commitment to enhancing the quality of life for elderly populations.
Who invested in Rejuvenate Biomed NV
2 investors across 2 rounds
See all investors in Rejuvenate Biomed NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rejuvenate Biomed NV
Who invested in Rejuvenate Biomed NV?
Rejuvenate Biomed NV has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rejuvenate Biomed NV raised?
Rejuvenate Biomed NV has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rejuvenate Biomed NV last raise money?
Rejuvenate Biomed NV's most recent round on record is a Series B, in Apr 2022.
What does Rejuvenate Biomed NV do?
Founded in 2017 and headquartered in Belgium, Rejuvenate Biomed NV specializes in therapeutic solutions for age-related health issues.
Where is Rejuvenate Biomed NV headquartered?
Rejuvenate Biomed NV is headquartered in Belgium.
Which VCs invest in companies like Rejuvenate Biomed NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Rejuvenate Biomed NV's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Rejuvenate Biomed NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.